Established in 1985 and listed on the Australian Securities Exchange (ASX:CGF) in 1987, Challenger Limited (Challenger) is an investment management firm managing more than $48.8 billion in assets*.
Challenger is focused on providing Australians with financial security in retirement. We do this by investing to create wealth in the accumulation phase of superannuation, and by converting accumulated wealth into safe and reliable income streams for retirees.
Challenger operates two core investment businesses, a fiduciary Funds Management division and an APRA-regulated Life division.
Challenger's Funds Management division manages more than $45 billion* and comprises Fidante Partners, which teams with boutique fund managers striving to deliver superior performance, as well as the Challenger Investment Partners (CIP) business. CIP is a relative value investor, accessing opportunities globally across real estate, fixed income and infrastructure on behalf of institutional investors, including Challenger Life Company.
Challenger Life Company Limited (Challenger Life) is Australia's largest provider of annuities and a life company registered under the Life Insurance Act 1995. Challenger Life guarantees the capital and interest in annuitants' regular payments, providing reliable income to around 60,000 investors through its management of $10.9 billion* in assets. It is regulated by the Australian Prudential Regulation Authority (APRA) and must hold a minimum amount of capital, set by APRA, to ensure it can meet all investors' payments into the future.
Challenger Life was named winner of the AFA/Plan for Life 'Annuity Provider of the Year' for the fifth year in a row in 2012, the most recent year in which this award was bestowed. Challenger Life also won the Long-Term Income Stream Award and the Income Stream Innovation Award for our Care Annuity. These awards are issued by AFA (Association of Financial Advisers) and Plan for Life Actuaries and Researchers. For further information about these awards, please refer to the AFA website.